|Articles|May 15, 2021
- BioPharm International-05-15-2021
- Volume 2021 eBook
- Issue 2
CDMO Partnerships Boost Company Capabilities
Author(s)Lauren Lavelle
Recent CDMO partnerships include COVID-19 collaborations, manufacturing partnerships, service agreements, and a strategic alliance expansion.
Advertisement
Collaboration between contract development and manufacturing organizations (CDMOs) is often necessary to reach certain manufacturing and development goals. The following is a sampling of recent CDMO partnerships in 2021 so far.
About the Author
Lauren Lavelle is assistant editor for BioPharm International.
Article Details
BioPharm International
eBook: Partnerships for Outsourcing, May 2021
May 2021
Pages: 34–38
Citation
When referring to this article, please cite it as L. Lavelle, “CDMO Partnerships Boost Company Capabilities," BioPharm International Partnerships for Outsourcing eBook (May 2021).
Articles in this issue
over 4 years ago
CDMO Landscape Seeing Changes as Consolidation Continuesover 4 years ago
RNA’s Expanding Horizonsover 4 years ago
Challenges When Outsourcing Viral Safety Servicesover 4 years ago
Ensuring Contract Manufacturing Facilities Are Up to Speedover 4 years ago
Succeeding with Remote Auditsover 4 years ago
Demystifying Complex Clinical Trial Kit PrepNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
